1. Home
  2. NXL vs GFAI Comparison

NXL vs GFAI Comparison

Compare NXL & GFAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • GFAI
  • Stock Information
  • Founded
  • NXL 2010
  • GFAI 2018
  • Country
  • NXL United States
  • GFAI Singapore
  • Employees
  • NXL N/A
  • GFAI N/A
  • Industry
  • NXL Medical Specialities
  • GFAI Diversified Commercial Services
  • Sector
  • NXL Health Care
  • GFAI Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • GFAI Nasdaq
  • Market Cap
  • NXL 24.2M
  • GFAI 20.7M
  • IPO Year
  • NXL 2022
  • GFAI N/A
  • Fundamental
  • Price
  • NXL $1.15
  • GFAI $1.03
  • Analyst Decision
  • NXL Strong Buy
  • GFAI Strong Buy
  • Analyst Count
  • NXL 1
  • GFAI 2
  • Target Price
  • NXL $5.00
  • GFAI $6.75
  • AVG Volume (30 Days)
  • NXL 121.2K
  • GFAI 214.9K
  • Earning Date
  • NXL 05-20-2025
  • GFAI 04-28-2025
  • Dividend Yield
  • NXL N/A
  • GFAI N/A
  • EPS Growth
  • NXL N/A
  • GFAI N/A
  • EPS
  • NXL N/A
  • GFAI N/A
  • Revenue
  • NXL $168,721.00
  • GFAI $36,347,373.00
  • Revenue This Year
  • NXL $79.59
  • GFAI $5.80
  • Revenue Next Year
  • NXL $334.65
  • GFAI $4.56
  • P/E Ratio
  • NXL N/A
  • GFAI N/A
  • Revenue Growth
  • NXL 52.35
  • GFAI 0.18
  • 52 Week Low
  • NXL $0.53
  • GFAI $0.76
  • 52 Week High
  • NXL $4.49
  • GFAI $3.88
  • Technical
  • Relative Strength Index (RSI)
  • NXL 22.27
  • GFAI 49.17
  • Support Level
  • NXL $1.75
  • GFAI $0.99
  • Resistance Level
  • NXL $1.39
  • GFAI $1.07
  • Average True Range (ATR)
  • NXL 0.13
  • GFAI 0.06
  • MACD
  • NXL -0.05
  • GFAI 0.00
  • Stochastic Oscillator
  • NXL 0.01
  • GFAI 29.10

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About GFAI Guardforce AI Co. Limited

Guardforce AI Co Ltd is a provider of cash solutions and cash handling services located in Thailand. The company engages in the cash logistics business, and its services include cash-in-transit, or CIT, dedicated vehicles to banks, ATM management, cash center operations, cash processing, coin processing, cheque center, and cash deposit machine solutions (cash deposit management and express cash service). Its customers include local commercial banks, chain retailers, coin-manufacturing mints, and government authorities.

Share on Social Networks: